Imugene Ltd. is a biopharmaceutical company, which engages in the research and development of drug delivery technologies. The company was founded on May 30, 1986 and is headquartered in Carlton, Australia.
|Market Price at 23-11-2017||$0.02|
|Price to Earnings Ratio||-11.54|
|Market Capitalisation||$45.03 (million)|
|Return on Equity (ROE)||-22.04%|
Blog posts that reference Imugene:
No articles found!